Ligand Pharmaceuticals, Inc. (LGND)
201.15
-2.67
(-1.31%)
USD |
NASDAQ |
Jan 23, 16:00
201.06
-0.09
(-0.04%)
After-Hours: 20:00
Ligand Pharmaceuticals Research and Development Expense (TTM): 82.10M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Merck & Co., Inc. | 14.26B |
| Johnson & Johnson | 14.70B |
| Elanco Animal Health, Inc. | 356.00M |
| Ionis Pharmaceuticals, Inc. | 879.75M |
| Krystal Biotech, Inc. | 55.37M |